This is a citizen science site -- you can contribute by investing and sharing your time.
Common knowledge amoung some professionals (MD and ND):
Omega-3 Fatty Acids: Omega-3 fatty acids found in fish oil or certain plant-based sources may have anti-inflammatory properties that could potentially benefit individuals with NAFLD by reducing liver fat and inflammation. They might be helpful in managing some aspects of the condition, although more research is needed.
Vitamin E: In some cases, vitamin E supplementation might be considered for individuals with NAFLD, particularly nonalcoholic steatohepatitis (NASH), the more severe form of NAFLD. Vitamin E might help reduce liver inflammation in some individuals, but it should be used under medical supervision due to potential risks at higher doses.
Probiotics: Some studies suggest that probiotics might have a potential role in improving liver enzyme levels and reducing liver fat in NAFLD patients by modulating the gut microbiota. However, more research is needed to determine specific strains, dosages, and their effects on NAFLD.
Vitamin D: Adequate levels of vitamin D are essential for overall health. Some research suggests an association between low vitamin D levels and NAFLD severity, but its direct impact on the condition requires further investigation.
Antioxidants: Some antioxidants, such as vitamin C, vitamin E, and selenium, might have potential benefits due to their ability to counteract oxidative stress, which plays a role in liver damage. However, their specific role in NAFLD management is still under study.
The Studies below identify bacteria. Check if it has already been reviewed.
| 1 | 📚 |
[Specific changes of intestinal microflora in children with nonalcoholic fatty liver disease].
Zhonghua er ke za zhi = Chinese journal of pediatrics (Zhonghua Er Ke Za Zhi ) Vol: 56 Issue: 11 Pages: 850-855 Pub: 2018 Nov 2 ePub: Authors Ling JR,Zhang YJ,Zhang ZH,He BH,Ni W,Shi WQ,Chen ZY |
| 2 | 📚 |
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease.
Nature communications (Nat Commun ) Vol: 10 Issue: 1 Pages: 1406 Pub: 2019 Mar 29 ePub: 2019 Mar 29 Authors Caussy C,Tripathi A,Humphrey G,Bassirian S,Singh S,Faulkner C,Bettencourt R,Rizo E,Richards L,Xu ZZ,Downes MR,Evans RM,Brenner DA,Sirlin CB,Knight R,Loomba R |
| 3 | 📚 |
A High-Fat Diet Increases the Characteristics of Gut Microbial Composition and the Intestinal Damage Associated with Non-Alcoholic Fatty Liver Disease.
International journal of molecular sciences (Int J Mol Sci ) Vol: 24 Issue: 23 Pages: Pub: 2023 Nov 24 ePub: 2023 Nov 24 Authors Zhu X,Cai J,Wang Y,Liu X,Chen X,Wang H,Wu Z,Bao W,Fan H,Wu S |
| 4 | 📚 |
A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD.
Scientific reports (Sci Rep ) Vol: 10 Issue: 1 Pages: 2771 Pub: 2020 Feb 17 ePub: 2020 Feb 17 Authors Dong TS,Katzka W,Lagishetty V,Luu K,Hauer M,Pisegna J,Jacobs JP |
| 5 | 📚 |
Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD.
Physiological genomics (Physiol Genomics ) Vol: 53 Issue: 8 Pages: 336-348 Pub: 2021 Aug 1 ePub: 2021 Jun 21 Authors Jiao N,Loomba R,Yang ZH,Wu D,Fang S,Bettencourt R,Lan P,Zhu R,Zhu L |
| 6 | 📚 |
Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease.
FEMS microbiology ecology (FEMS Microbiol Ecol ) Vol: 91 Issue: 2 Pages: 1-9 Pub: 2015 Feb ePub: 2014 Dec 5 Authors Michail S,Lin M,Frey MR,Fanter R,Paliy O,Hilbush B,Reo NV |
| 7 | 📚 |
An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity.
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (Rev Esp Enferm Dig ) Vol: 111 Issue: 4 Pages: 275-282 Pub: 2019 Apr ePub: Authors Nistal E,Sáenz de Miera LE,Ballesteros Pomar M,Sánchez-Campos S,García-Mediavilla MV,Álvarez-Cuenllas B,Linares P,Olcoz JL,Arias-Loste MT,García-Lobo JM,Crespo J,González-Gallego J,Jorquera Plaza F |
| 8 | 📚 |
Association between nonalcoholic fatty liver disease and Helicobacter pylori infection in Dali City, China.
Saudi medical journal (Saudi Med J ) Vol: 42 Issue: 7 Pages: 735-741 Pub: 2021 Jul ePub: Authors Yan P,Yu B,Li M,Zhao W |
| 9 | 📚 |
Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?
Archives of medical science : AMS (Arch Med Sci ) Vol: 14 Issue: 1 Pages: 81-87 Pub: 2018 Jan ePub: 2016 Sep 6 Authors Nobili V,Putignani L,Mosca A,Del Chierico F,Vernocchi P,Alisi A,Stronati L,Cucchiara S,Toscano M,Drago L |
| 10 | 📚 |
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
PloS one (PLoS One ) Vol: 11 Issue: 5 Pages: e0151829 Pub: 2016 ePub: 2016 May 20 Authors Mouzaki M,Wang AY,Bandsma R,Comelli EM,Arendt BM,Zhang L,Fung S,Fischer SE,McGilvray IG,Allard JP |
| 11 | 📚 |
Changes in the intestinal microbiota of individuals with non-alcoholic fatty liver disease based on sequencing: An updated systematic review and meta-analysis.
PloS one (PLoS One ) Vol: 19 Issue: 3 Pages: e0299946 Pub: 2024 ePub: 2024 Mar 28 Authors Cai W,Qiu T,Hu W,Fang T |
| 12 | 📚 |
Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients.
Science China. Life sciences (Sci China Life Sci ) Vol: 61 Issue: 7 Pages: 770-778 Pub: 2018 Jul ePub: 2018 Jun 8 Authors Li F,Sun G,Wang Z,Wu W,Guo H,Peng L,Wu L,Guo X,Yang Y |
| 13 | 📚 |
Characterization of the hepatic flora and metabolome in nonalcoholic fatty liver disease.
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue: Pages: 1528258 Pub: 2024 ePub: 2024 Dec 20 Authors Jiang H,Wang H,Guo Y,Zhu Y,Dai H,Liang C,Gao J |
| 14 | 📚 |
Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy-proven non-alcoholic fatty liver disease.
Liver international : official journal of the International Association for the Study of the Liver (Liver Int ) Vol: 41 Issue: 7 Pages: 1576-1591 Pub: 2021 Jul ePub: 2021 May 7 Authors Lang S,Martin A,Zhang X,Farowski F,Wisplinghoff H,J G T Vehreschild M,Krawczyk M,Nowag A,Kretzschmar A,Scholz C,Kasper P,Roderburg C,Mohr R,Lammert F,Tacke F,Schnabl B,Goeser T,Steffen HM,Demir M |
| 15 | 📚 |
Composition of gut microbiota and non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Obesity reviews : an official journal of the International Association for the Study of Obesity (Obes Rev ) Vol: 25 Issue: 1 Pages: e13646 Pub: 2024 Jan ePub: 2023 Oct 9 Authors Su X,Chen S,Liu J,Feng Y,Han E,Hao X,Liao M,Cai J,Zhang S,Niu J,He S,Huang S,Lo K,Zeng F |
| 16 | 📚 |
Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis.
Lipids in health and disease (Lipids Health Dis ) Vol: 20 Issue: 1 Pages: 22 Pub: 2021 Feb 26 ePub: 2021 Feb 26 Authors Li F,Ye J,Shao C,Zhong B |
| 17 | 📚 |
Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine.
Gut microbes (Gut Microbes ) Vol: 16 Issue: 1 Pages: 2351620 Pub: 2024 Jan-Dec ePub: 2024 May 13 Authors Wei J,Luo J,Yang F,Feng X,Zeng M,Dai W,Pan X,Yang Y,Li Y,Duan Y,Xiao X,Ye P,Yao Z,Liu Y,Huang Z,Zhang J,Zhong Y,Xu N,Luo M |
| 18 | 📚 |
Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease.
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 11 Issue: Pages: 698852 Pub: 2021 ePub: 2021 Sep 9 Authors Yu J,Zhang H,Chen L,Ruan Y,Chen Y,Liu Q |
| 19 | 📚 |
Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD.
Nature communications (Nat Commun ) Vol: 11 Issue: 1 Pages: 4982 Pub: 2020 Oct 5 ePub: 2020 Oct 5 Authors Lee G,You HJ,Bajaj JS,Joo SK,Yu J,Park S,Kang H,Park JH,Kim JH,Lee DH,Lee S,Kim W,Ko G |
| 20 | 📚 |
Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease.
Scientific reports (Sci Rep ) Vol: 5 Issue: Pages: 8096 Pub: 2015 Feb 3 ePub: 2015 Feb 3 Authors Jiang W,Wu N,Wang X,Chi Y,Zhang Y,Qiu X,Hu Y,Li J,Liu Y |
| 21 | 📚 |
Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth.
The Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab ) Vol: 105 Issue: 10 Pages: e3575-85 Pub: 2020 Oct 1 ePub: Authors Monga Kravetz A,Testerman T,Galuppo B,Graf J,Pierpont B,Siebel S,Feinn R,Santoro N |
| 22 | 📚 |
Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association (Clin Gastroenterol Hepatol ) Vol: 11 Issue: 7 Pages: 868-75.e1-3 Pub: 2013 Jul ePub: 2013 Feb 27 Authors Raman M,Ahmed I,Gillevet PM,Probert CS,Ratcliffe NM,Smith S,Greenwood R,Sikaroodi M,Lam V,Crotty P,Bailey J,Myers RP,Rioux KP |
| 23 | 📚 |
Gut Microbiota and Host Reaction in Liver Diseases.
Microorganisms (Microorganisms ) Vol: 3 Issue: 4 Pages: 759-91 Pub: 2015 Oct 28 ePub: 2015 Oct 28 Authors Fukui H |
| 24 | 📚 |
Gut microbiota and mycobiota change with feeding duration in mice on a high-fat and high-fructose diet.
BMC microbiology (BMC Microbiol ) Vol: 24 Issue: 1 Pages: 504 Pub: 2024 Nov 29 ePub: 2024 Nov 29 Authors Zheng R,Xiang X,Shi Y,Xie J,Xing L,Zhang T,Zhou Z,Zhang D |
| 25 | 📚 |
Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease.
Journal of gastroenterology and hepatology (J Gastroenterol Hepatol ) Vol: Issue: Pages: Pub: 2021 Mar 11 ePub: 2021 Mar 11 Authors Iwaki M,Kessoku T,Ozaki A,Kasai Y,Kobayashi T,Nogami A,Honda Y,Ogawa Y,Imajo K,Yoneda M,Maeda A,Tanaka Y,Nakajima S,Ohno H,Usuda H,Kawanaka M,Kawaguchi T,Torimura T,Kage M,Hyogo H,Takahashi H,Eguchi Y,Aishima S,Wada K,Kobayash N,Sumida Y,Saito S,Nakajima A |
| 26 | 📚 |
Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
Hepatobiliary & pancreatic diseases international : HBPD INT (Hepatobiliary Pancreat Dis Int ) Vol: 16 Issue: 4 Pages: 375-381 Pub: 2017 Aug 15 ePub: Authors Shen F,Zheng RD,Sun XQ,Ding WJ,Wang XY,Fan JG |
| 27 | 📚 |
Gut microbiota in nonalcoholic fatty liver diseases with and without type-2 diabetes mellitus.
European journal of gastroenterology & hepatology (Eur J Gastroenterol Hepatol ) Vol: Issue: Pages: Pub: 2021 Apr 9 ePub: 2021 Apr 9 Authors Ebrahimzadeh Leylabadlo H,Samadi Kafil H,Farajnia S,Shanehbandi D,Yaghoub Moaddab S,Feizabadi MM,Ghotaslou R |
| 28 | 📚 |
Gut Microbiota in Patients with Non-Alcoholic Fatty Liver Disease without Type 2 Diabetes: Stratified by Body Mass Index.
International journal of molecular sciences (Int J Mol Sci ) Vol: 25 Issue: 3 Pages: Pub: 2024 Feb 2 ePub: 2024 Feb 2 Authors Chuaypen N,Asumpinawong A,Sawangsri P,Khamjerm J,Iadsee N,Jinato T,Sutheeworapong S,Udomsawaengsup S,Tangkijvanich P |
| 29 | 📚 |
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study.
International journal of molecular sciences (Int J Mol Sci ) Vol: 25 Issue: 10 Pages: Pub: 2024 May 17 ePub: 2024 May 17 Authors De Caro C,Spagnuolo R,Quirino A,Mazza E,Carrabetta F,Maurotti S,Cosco C,Bennardo F,Roberti R,Russo E,Giudice A,Pujia A,Doldo P,Matera G,Marascio N |
| 30 | 📚 |
Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.
Hepatology (Baltimore, Md.) (Hepatology ) Vol: 65 Issue: 2 Pages: 451-464 Pub: 2017 Feb ePub: 2016 Jun 2 Authors Del Chierico F,Nobili V,Vernocchi P,Russo A,De Stefanis C,Gnani D,Furlanello C,Zandonà A,Paci P,Capuani G,Dallapiccola B,Miccheli A,Alisi A,Putignani L |
| 31 | 📚 |
Helicobacter pylori infection increases the risk of nonalcoholic fatty liver disease: Possible relationship from an updated meta-analysis.
Medicine (Medicine (Baltimore) ) Vol: 102 Issue: 33 Pages: e34605 Pub: 2023 Aug 18 ePub: Authors Liu C,Wu Q,Ren R,Zhang Z,Shi Y,Li H |
| 32 | 📚 |
Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets.
Archives of microbiology (Arch Microbiol ) Vol: 206 Issue: 2 Pages: 62 Pub: 2024 Jan 13 ePub: 2024 Jan 13 Authors Gruzdev SK,Podoprigora IV,Gizinger OA |
| 33 | 📚 |
Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.
Journal of gastroenterology (J Gastroenterol ) Vol: 53 Issue: 2 Pages: 269-280 Pub: 2018 Feb ePub: 2017 Jul 24 Authors Nakahara T,Hyogo H,Ono A,Nagaoki Y,Kawaoka T,Miki D,Tsuge M,Hiraga N,Hayes CN,Hiramatsu A,Imamura M,Kawakami Y,Aikata H,Ochi H,Abe-Chayama H,Furusho H,Shintani T,Kurihara H,Miyauchi M,Takata T,Arihiro K,Chayama K |
| 34 | 📚 |
Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
Microbiology spectrum (Microbiol Spectr ) Vol: 10 Issue: 3 Pages: e0004722 Pub: 2022 Jun 29 ePub: 2022 Jun 1 Authors Zhuge A,Li S,Lou P,Wu W,Wang K,Yuan Y,Xia J,Li B,Li L |
| 35 | 📚 |
Lower gut microbiome diversity and higher abundance of proinflammatory genus <i>Collinsella</i> are associated with biopsy-proven nonalcoholic steatohepatitis.
Gut microbes (Gut Microbes ) Vol: Issue: Pages: 1-12 Pub: 2019 Nov 7 ePub: 2019 Nov 7 Authors Astbury S,Atallah E,Vijay A,Aithal GP,Grove JI,Valdes AM |
| 36 | 📚 |
Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury.
Pharmacological research (Pharmacol Res ) Vol: 182 Issue: Pages: 106348 Pub: 2022 Aug ePub: 2022 Jul 8 Authors Rodriguez-Diaz C,Taminiau B,García-García A,Cueto A,Robles-Díaz M,Ortega-Alonso A,Martín-Reyes F,Daube G,Sanabria-Cabrera J,Jimenez-Perez M,Isabel Lucena M,Andrade RJ,García-Fuentes E,García-Cortes M |
| 37 | 📚 |
New insights from uncultivated genomes of the global human gut microbiome.
Nature (Nature ) Vol: 568 Issue: 7753 Pages: 505-510 Pub: 2019 Apr ePub: 2019 Mar 13 Authors Nayfach S,Shi ZJ,Seshadri R,Pollard KS,Kyrpides NC |
| 38 | 📚 |
NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice.
American journal of physiology. Endocrinology and metabolism (Am J Physiol Endocrinol Metab ) Vol: 319 Issue: 2 Pages: E305-E314 Pub: 2020 Aug 1 ePub: 2020 Jun 9 Authors Cavallari JF,Pokrajac NT,Zlitni S,Foley KP,Henriksbo BD,Schertzer JD |
| 39 | 📚 |
Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?
Journal of gastroenterology and hepatology (J Gastroenterol Hepatol ) Vol: 35 Issue: 11 Pages: 1969-1977 Pub: 2020 Nov ePub: 2020 Apr 30 Authors Demir M,Lang S,Martin A,Farowski F,Wisplinghoff H,Vehreschild MJGT,Krawczyk M,Nowag A,Scholz CJ,Kretzschmar A,Roderburg C,Lammert F,Goeser T,Kasper P,Steffen HM |
| 40 | 📚 |
Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J ) Vol: 35 Issue: 6 Pages: e21458 Pub: 2021 Jun ePub: Authors Wang X,Liu D,Wang Z,Cai C,Jiang H,Yu G |
| 41 | 📚 |
Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools.
Scientific reports (Sci Rep ) Vol: 10 Issue: 1 Pages: 9385 Pub: 2020 Jun 10 ePub: 2020 Jun 10 Authors Lang S,Farowski F,Martin A,Wisplinghoff H,Vehreschild MJGT,Krawczyk M,Nowag A,Kretzschmar A,Scholz C,Kasper P,Roderburg C,Lammert F,Goeser T,Steffen HM,Demir M |
| 42 | 📚 |
Reduced Equol Production and Gut Microbiota Features in Men With Lean Nonalcoholic Fatty Liver Disease.
American journal of men's health (Am J Mens Health ) Vol: 16 Issue: 4 Pages: 15579883221115598 Pub: 2022 Jul-Aug ePub: Authors Iino C,Endo T,Iino K,Tateda T,Sato S,Igarashi G,Mikami K,Sakuraba H,Yokoyama Y,Nakaji S,Fukuda S |
| 43 | 📚 |
Relationship between Changes in Microbiota and Liver Steatosis Induced by High-Fat Feeding-A Review of Rodent Models.
Nutrients (Nutrients ) Vol: 11 Issue: 9 Pages: Pub: 2019 Sep 9 ePub: 2019 Sep 9 Authors Gómez-Zorita S,Aguirre L,Milton-Laskibar I,Fernández-Quintela A,Trepiana J,Kajarabille N,Mosqueda-Solís A,González M,Portillo MP |
| 44 | 📚 |
Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives.
Frontiers of medicine (Front Med ) Vol: 16 Issue: 5 Pages: 667-685 Pub: 2022 Oct ePub: 2022 Nov 1 Authors Han Y,Li L,Wang B |
| 45 | 📚 |
Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study.
Hepatology international (Hepatol Int ) Vol: Issue: Pages: Pub: 2019 Sep 12 ePub: 2019 Sep 12 Authors Iino C,Endo T,Mikami K,Hasegawa T,Kimura M,Sawada N,Nakaji S,Fukuda S |
| 46 | 📚 |
Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease diagnosed by transient elastography and liver biopsy.
International journal of clinical practice (Int J Clin Pract ) Vol: 75 Issue: 4 Pages: e13947 Pub: 2021 Apr ePub: 2021 Feb 16 Authors Mikolasevic I,Delija B,Mijic A,Stevanovic T,Skenderevic N,Sosa I,Krznaric-Zrnic I,Abram M,Krznaric Z,Domislovic V,Filipec Kanizaj T,Radic-Kristo D,Cubranic A,Grubesic A,Nakov R,Skrobonja I,Stimac D,Hauser G |
| 47 | 📚 |
Specific Strains of Faecalibacterium prausnitzii Ameliorate Nonalcoholic Fatty Liver Disease in Mice in Association with Gut Microbiota Regulation.
Nutrients (Nutrients ) Vol: 14 Issue: 14 Pages: Pub: 2022 Jul 19 ePub: 2022 Jul 19 Authors Hu W,Gao W,Liu Z,Fang Z,Wang H,Zhao J,Zhang H,Lu W,Chen W |
| 48 | 📚 |
The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease.
Current gastroenterology reports (Curr Gastroenterol Rep ) Vol: 19 Issue: 2 Pages: 5 Pub: 2017 Feb ePub: Authors Tang DM,Kumar S |
| 49 | 📚 |
The Microbiota and It's Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease.
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 12 Issue: Pages: 870785 Pub: 2022 ePub: 2022 May 27 Authors Gu C,Zhou Z,Yu Z,He M,He L,Luo Z,Xiao W,Yang Q,Zhao F,Li W,Shen L,Han J,Cao S,Zuo Z,Deng J,Yan Q,Ren Z,Zhao M,Yu S |
| 50 | 📚 |
The Relationship Between Bacterial Changes and Dietary Intervention in Non-Alcoholic Fatty Liver Disease.
Clinical nutrition ESPEN (Clin Nutr ESPEN ) Vol: Issue: Pages: Pub: 2025 May 7 ePub: 2025 May 7 Authors Oguz E,Yilmaz Y,Günes FE |
| 51 | 📚 |
The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease.
Frontiers in microbiology (Front Microbiol ) Vol: 14 Issue: Pages: 1257903 Pub: 2023 ePub: 2024 Jan 5 Authors Mai H,Yang X,Xie Y,Zhou J,Wang Q,Wei Y,Yang Y,Lu D,Ye L,Cui P,Liang H,Huang J |
| 52 | 📚 |
Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection.
International journal of clinical practice (Int J Clin Pract ) Vol: 75 Issue: 4 Pages: e13737 Pub: 2021 Apr ePub: 2020 Nov 21 Authors Doulberis M,Papaefthymiou A,Srivastava DS,Exadaktylos AK,Katsinelos P,Kountouras J,Polyzos SA |
| 53 | 📚 |
Variation in the Plasma Levels of Polyunsaturated Fatty Acids in Control vis-à-vis Nonalcoholic Fatty Liver Disease Subjects and Its Possible Association with Gut Microbiome.
Metabolic syndrome and related disorders (Metab Syndr Relat Disord ) Vol: 16 Issue: 7 Pages: 329-335 Pub: 2018 Sep ePub: 2018 Jun 6 Authors Vernekar M,Singhal R,Joshi K,Amarapurkar D |
The Studies below identify substances that has been tried with positive changes (for at least some symptoms in the study). Check if it has already been reviewed.
| 54 | 📚 |
[Effects of aerobic exercise on CNPY2-PERK pathway in the liver of mice with non-alcoholic fatty liver disease].
Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology (Zhongguo Ying Yong Sheng Li Xue Za Zhi ) Vol: 38 Issue: 3 Pages: 193-198 Pub: 2022 Sep ePub: Authors Li JH,Xiong W,Wang JQ,Li YL,Jiang CJ |
| 55 | 📚 |
A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysis.
Artificial cells, nanomedicine, and biotechnology (Artif Cells Nanomed Biotechnol ) Vol: 52 Issue: 1 Pages: 250-260 Pub: 2024 Dec ePub: 2024 Apr 30 Authors Lee SB,Gupta H,Min BH,Ganesan R,Sharma SP,Won SM,Jeong JJ,Cha MG,Kwon GH,Jeong MK,Hyun JY,Eom JA,Park HJ,Yoon SJ,Lee SY,Choi MR,Kim DJ,Oh KK,Suk KT |
| 56 | 📚 |
A Healthful Plant-Based Diet Is Associated with Lower Odds of Nonalcoholic Fatty Liver Disease.
Nutrients (Nutrients ) Vol: 14 Issue: 19 Pages: Pub: 2022 Oct 2 ePub: 2022 Oct 2 Authors Li X,Peng Z,Li M,Zeng X,Li H,Zhu Y,Chen H,Hu A,Zhao Q,Zhang Z,Wang H,Yuan C,Yang W |
| 57 | 📚 |
Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis.
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue: Pages: 861854 Pub: 2022 ePub: 2022 May 17 Authors Zhu W,Zhou Y,Tsao R,Dong H,Zhang H |
| 58 | 📚 |
Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota.
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue: Pages: 913378 Pub: 2022 ePub: 2022 Jul 8 Authors Yang S,Cao S,Li C,Zhang J,Liu C,Qiu F,Kang N |
| 59 | 📚 |
Beverage consumption in patients with metabolic syndrome and its association with non-alcoholic fatty liver disease: a cross-sectional study.
Frontiers in nutrition (Front Nutr ) Vol: 11 Issue: Pages: 1257969 Pub: 2024 ePub: 2024 Jan 22 Authors Kositamongkol C,Ngaohirunpat S,Samchusri S,Chaisathaphol T,Srivanichakorn W,Washirasaksiri C,Auesomwang C,Sitasuwan T,Tinmanee R,Sayabovorn N,Charatcharoenwitthaya P,Phisalprapa P |
| 60 | 📚 |
Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis.
Biomedicines (Biomedicines ) Vol: 10 Issue: 1 Pages: Pub: 2021 Dec 31 ePub: 2021 Dec 31 Authors Wang L,Jiao T,Yu Q,Wang J,Wang L,Wang G,Zhang H,Zhao J,Chen W |
| 61 | 📚 |
Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.
Frontiers in microbiology (Front Microbiol ) Vol: 14 Issue: Pages: 1129904 Pub: 2023 ePub: 2023 Mar 1 Authors Yoon SJ,Yu JS,Min BH,Gupta H,Won SM,Park HJ,Han SH,Kim BY,Kim KH,Kim BK,Joung HC,Park TS,Ham YL,Lee DY,Suk KT |
| 62 | 📚 |
Biosynthetic deficiency of docosahexaenoic acid causes nonalcoholic fatty liver disease and ferroptosis-mediated hepatocyte injury.
The Journal of biological chemistry (J Biol Chem ) Vol: 300 Issue: 7 Pages: 107405 Pub: 2024 May 22 ePub: 2024 May 22 Authors Li X,Liu C,Zhang R,Li Y,Ye D,Wang H,He M,Sun Y |
| 63 | 📚 |
Burdock (Arctium lappa L.) root attenuates preneoplastic lesion development in a diet and thioacetamide-induced model of steatohepatitis-associated hepatocarcinogenesis.
Environmental toxicology (Environ Toxicol ) Vol: 35 Issue: 4 Pages: 518-527 Pub: 2020 Apr ePub: 2019 Dec 5 Authors Romualdo GR,Silva EDA,Da Silva TC,Aloia TPA,Nogueira MS,De Castro IA,Vinken M,Barbisan LF,Cogliati B |
| 64 | 📚 |
Combined Amelioration of Prebiotic Resveratrol and Probiotic Bifidobacteria on Obesity and Nonalcoholic Fatty Liver Disease.
Nutrition and cancer (Nutr Cancer ) Vol: 73 Issue: 4 Pages: 652-661 Pub: 2021 ePub: 2020 May 21 Authors Hu D,Yang W,Mao P,Cheng M |
| 65 | 📚 |
Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway.
Oxidative medicine and cellular longevity (Oxid Med Cell Longev ) Vol: 2014 Issue: Pages: 469059 Pub: 2014 ePub: 2014 Nov 27 Authors Ren T,Huang C,Cheng M |
| 66 | 📚 |
Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function.
Journal of ginseng research (J Ginseng Res ) Vol: 45 Issue: 2 Pages: 316-324 Pub: 2021 Mar ePub: 2020 Jul 16 Authors Hong JT,Lee MJ,Yoon SJ,Shin SP,Bang CS,Baik GH,Kim DJ,Youn GS,Shin MJ,Ham YL,Suk KT,Kim BS |
| 67 | 📚 |
Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet.
The Journal of nutritional biochemistry (J Nutr Biochem ) Vol: 25 Issue: 1 Pages: 81-90 Pub: 2014 Jan ePub: 2013 Oct 10 Authors Raso GM,Simeoli R,Iacono A,Santoro A,Amero P,Paciello O,Russo R,D'Agostino G,Di Costanzo M,Canani RB,Calignano A,Meli R |
| 68 | 📚 |
Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial.
Journal of the American College of Nutrition (J Am Coll Nutr ) Vol: 35 Issue: 6 Pages: 500-505 Pub: 2016 Aug ePub: 2015 Oct 2 Authors Sepideh A,Karim P,Hossein A,Leila R,Hamdollah M,Mohammad E G,Mojtaba S,Mohammad S,Ghader G,Seyed Moayed A |
| 69 | 📚 |
Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids.
Journal of clinical biochemistry and nutrition (J Clin Biochem Nutr ) Vol: 67 Issue: 1 Pages: 2-9 Pub: 2020 Jul ePub: 2020 Jun 3 Authors Naito Y,Ushiroda C,Mizushima K,Inoue R,Yasukawa Z,Abe A,Takagi T |
| 70 | 📚 |
Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 320 Issue: Pages: 117395 Pub: 2024 Feb 10 ePub: 2023 Nov 11 Authors Thakuri LS,Park CM,Kim HA,Kim HJ,Park JW,Park JC,Rhyu DY |
| 71 | 📚 |
Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways.
European journal of pharmacology (Eur J Pharmacol ) Vol: 887 Issue: Pages: 173461 Pub: 2020 Nov 15 ePub: 2020 Aug 3 Authors Ahmed LA,Salem MB,Seif El-Din SH,El-Lakkany NM,Ahmed HO,Nasr SM,Hammam OA,Botros SS,Saleh S |
| 72 | 📚 |
Hepatoprotective Effect of Lactiplantibacillus plantarum DSR330 in Mice with High Fat Diet-Induced Nonalcoholic Fatty Liver Disease.
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 34 Issue: 2 Pages: 399-406 Pub: 2024 Feb 28 ePub: 2023 Dec 8 Authors Lee NK,Lee Y,Shin DS,Ra J,Choi YM,Ryu BH,Lee J,Park E,Paik HD |
| 73 | 📚 |
Hepatoprotective potential of zingerone against nonalcoholic fatty liver disease in rats fed with fructose-enriched diet.
General physiology and biophysics (Gen Physiol Biophys ) Vol: 35 Issue: 2 Pages: 185-94 Pub: 2016 Apr ePub: 2016 Feb 26 Authors Muniandy Narayanan J,Jesudoss VA |
| 74 | 📚 |
Highland barley ß-glucan alleviated western diet-induced non-alcoholic fatty liver disease via increasing energy expenditure and regulating bile acid metabolism in mice.
Food & function (Food Funct ) Vol: 13 Issue: 22 Pages: 11664-11675 Pub: 2022 Nov 14 ePub: 2022 Nov 14 Authors Liu H,Sun Y,Nie C,Xie X,Yuan X,Ma Q,Zhang M,Chen Z,Hu X,Li J |
| 75 | 📚 |
Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A Review.
Plant foods for human nutrition (Dordrecht, Netherlands) (Plant Foods Hum Nutr ) Vol: 77 Issue: 3 Pages: 319-328 Pub: 2022 Sep ePub: 2022 Jun 9 Authors Xiao CW,Hendry A |
| 76 | 📚 |
Inverse Association Between Serum 25-Hydroxyvitamin D and Nonalcoholic Fatty Liver Disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association (Clin Gastroenterol Hepatol ) Vol: 21 Issue: 2 Pages: 398-405.e4 Pub: 2023 Feb ePub: 2022 Jan 31 Authors Yuan S,Larsson SC |
| 77 | 📚 |
Lactiplantibacillus plantarum ZDY2013 Inhibits the Development of Non-Alcoholic Fatty Liver Disease by Regulating the Intestinal Microbiota and Modulating the PI3K/Akt Pathway.
Nutrients (Nutrients ) Vol: 16 Issue: 7 Pages: Pub: 2024 Mar 27 ePub: 2024 Mar 27 Authors Teng Q,Lv H,Peng L,Ren Z,Chen J,Ma L,Wei H,Wan C |
| 78 | 📚 |
Lactobacillus acidophilus suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma through producing valeric acid.
EBioMedicine (EBioMedicine ) Vol: 100 Issue: Pages: 104952 Pub: 2024 Feb ePub: 2024 Jan 4 Authors Lau HC,Zhang X,Ji F,Lin Y,Liang W,Li Q,Chen D,Fong W,Kang X,Liu W,Chu ES,Ng QW,Yu J |
| 79 | 📚 |
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis.
Clinical and molecular hepatology (Clin Mol Hepatol ) Vol: 27 Issue: 1 Pages: 110-124 Pub: 2021 Jan ePub: 2020 Dec 3 Authors Lee NY,Shin MJ,Youn GS,Yoon SJ,Choi YR,Kim HS,Gupta H,Han SH,Kim BK,Lee DY,Park TS,Sung H,Kim BY,Suk KT |
| 80 | 📚 |
Lactobacillus casei YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathway.
The British journal of nutrition (Br J Nutr ) Vol: 125 Issue: 5 Pages: 521-529 Pub: 2021 Mar 14 ePub: 2020 Jul 28 Authors Zhang Z,Zhou H,Zhou X,Sun J,Liang X,Lv Y,Bai L,Zhang J,Gong P,Liu T,Yi H,Wang J,Zhang L |
| 81 | 📚 |
Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum.
Gut microbes (Gut Microbes ) Vol: 12 Issue: 1 Pages: 1829449 Pub: 2020 Nov 9 ePub: Authors Lee NY,Joung HC,Kim BK,Kim BY,Park TS,Suk KT |
| 82 | 📚 |
Lactobacillus plantarum NCU116 improves liver function, oxidative stress and lipid metabolism in rats with high fat diet induced non-alcoholic fatty liver disease.
Food & function (Food Funct ) Vol: 5 Issue: 12 Pages: 3216-23 Pub: 2014 Dec ePub: Authors Li C,Nie SP,Zhu KX,Ding Q,Li C,Xiong T,Xie MY |
| 83 | 📚 |
Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.
PloS one (PLoS One ) Vol: 9 Issue: 1 Pages: e80169 Pub: 2014 ePub: 2014 Jan 27 Authors Ritze Y,Bárdos G,Claus A,Ehrmann V,Bergheim I,Schwiertz A,Bischoff SC |
| 84 | 📚 |
Live Combined B. subtilis and E. faecium Alleviate Liver Inflammation, Improve Intestinal Barrier Function, and Modulate Gut Microbiota in Mice with Non-Alcoholic Fatty Liver Disease.
Medical science monitor : international medical journal of experimental and clinical research (Med Sci Monit ) Vol: 27 Issue: Pages: e931143 Pub: 2021 Sep 5 ePub: 2021 Sep 5 Authors Jiang J,Xiong J,Ni J,Chen C,Wang K |
| 85 | 📚 |
Management of non-alcoholic fatty liver disease: Lifestyle changes.
World journal of gastroenterology (World J Gastroenterol ) Vol: 30 Issue: 22 Pages: 2829-2833 Pub: 2024 Jun 14 ePub: Authors Lv H,Liu Y |
| 86 | 📚 |
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies.
Frontiers in nutrition (Front Nutr ) Vol: 11 Issue: Pages: 1355732 Pub: 2024 ePub: 2024 Mar 19 Authors Al Hashmi K,Giglio RV,Pantea Stoian A,Patti AM,Al Waili K,Al Rasadi K,Ciaccio M,Rizzo M |
| 87 | 📚 |
Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet.
Life sciences (Life Sci ) Vol: 310 Issue: Pages: 121110 Pub: 2022 Dec 1 ePub: 2022 Oct 20 Authors Wang S,Li XY,Ji HF,Shen L |
| 88 | 📚 |
Naringenin prevents non-alcoholic steatohepatitis by modulating the host metabolome and intestinal microbiome in MCD diet-fed mice.
Food science & nutrition (Food Sci Nutr ) Vol: 11 Issue: 12 Pages: 7826-7840 Pub: 2023 Dec ePub: 2023 Sep 27 Authors Cao P,Yue M,Cheng Y,Sullivan MA,Chen W,Yu H,Li F,Wu S,Lv Y,Zhai X,Zhang Y |
| 89 | 📚 |
Naringin Attenuates High Fat Diet Induced Non-alcoholic Fatty Liver Disease and Gut Bacterial Dysbiosis in Mice.
Frontiers in microbiology (Front Microbiol ) Vol: 11 Issue: Pages: 585066 Pub: 2020 ePub: 2020 Nov 13 Authors Mu H,Zhou Q,Yang R,Zeng J,Li X,Zhang R,Tang W,Li H,Wang S,Shen T,Huang X,Dou L,Dong J |
| 90 | 📚 |
Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver Disease.
International journal of molecular sciences (Int J Mol Sci ) Vol: 21 Issue: 24 Pages: Pub: 2020 Dec 14 ePub: 2020 Dec 14 Authors Stec DE,Hinds TD Jr |
| 91 | 📚 |
Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice.
Journal of personalized medicine (J Pers Med ) Vol: 14 Issue: 1 Pages: Pub: 2024 Jan 1 ePub: 2024 Jan 1 Authors Ali H,Shahzil M,Moond V,Shahzad M,Thandavaram A,Sehar A,Waseem H,Siddiqui T,Dahiya DS,Patel P,Tillmann H |
| 92 | 📚 |
Optimal probiotic combinations for treating nonalcoholic fatty liver disease: A systematic review and network meta-analysis.
Clinical nutrition (Edinburgh, Scotland) (Clin Nutr ) Vol: 43 Issue: 6 Pages: 1224-1239 Pub: 2024 Jun ePub: 2024 Apr 13 Authors Yang Y,Yang L,Wu J,Hu J,Wan M,Bie J,Li J,Pan D,Sun G,Yang C |
| 93 | 📚 |
Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters.
PloS one (PLoS One ) Vol: 8 Issue: 3 Pages: e58394 Pub: 2013 ePub: 2013 Mar 12 Authors Bhathena J,Martoni C,Kulamarva A,Tomaro-Duchesneau C,Malhotra M,Paul A,Urbanska AM,Prakash S |
| 94 | 📚 |
Orally Deliverable Sequence-Targeted Fucoxanthin-Loaded Biomimetic Extracellular Vesicles for Alleviation of Nonalcoholic Fatty Liver Disease.
ACS applied materials & interfaces (ACS Appl Mater Interfaces ) Vol: 16 Issue: 8 Pages: 9854-9867 Pub: 2024 Feb 28 ePub: 2024 Feb 20 Authors Wu C,Xiang S,Wang H,Zhang X,Tian X,Tan M,Su W |
| 95 | 📚 |
Phycobiliprotein Peptide Extracts from Arthrospira platensis Ameliorate Nonalcoholic Fatty Liver Disease by Modulating Hepatic Lipid Profile and Strengthening Fat Mobilization.
Nutrients (Nutrients ) Vol: 15 Issue: 21 Pages: Pub: 2023 Oct 27 ePub: 2023 Oct 27 Authors Liu J,Wu H,Zhang Y,Hu C,Zhen D,Fu P,He Y |
| 96 | 📚 |
Phytotherapy and NAFLD--from goals and challenges to clinical practice.
Reviews on recent clinical trials (Rev Recent Clin Trials ) Vol: 9 Issue: 3 Pages: 195-203 Pub: 2014 ePub: Authors Milosevic N,Milanovic M,Abenavoli L,Milic N |
| 97 | 📚 |
Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J ) Vol: 35 Issue: 6 Pages: e21458 Pub: 2021 Jun ePub: Authors Wang X,Liu D,Wang Z,Cai C,Jiang H,Yu G |
| 98 | 📚 |
Prebiotic inulin as a treatment of obesity related nonalcoholic fatty liver disease through gut microbiota: a critical review.
Critical reviews in food science and nutrition (Crit Rev Food Sci Nutr ) Vol: 63 Issue: 7 Pages: 862-872 Pub: 2023 ePub: 2021 Jul 22 Authors Hu Y,He J,Zheng P,Mao X,Huang Z,Yan H,Luo Y,Yu J,Luo J,Yu B,Chen D |
| 99 | 📚 |
Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice.
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 98 Issue: 15 Pages: 6817-29 Pub: 2014 Aug ePub: 2014 May 9 Authors Xin J,Zeng D,Wang H,Ni X,Yi D,Pan K,Jing B |
| 100 | 📚 |
Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease.
AMB Express (AMB Express ) Vol: 10 Issue: 1 Pages: 101 Pub: 2020 May 29 ePub: 2020 May 29 Authors Yan Y,Liu C,Zhao S,Wang X,Wang J,Zhang H,Wang Y,Zhao G |
| 101 | 📚 |
Probiotics and Non-Alcoholic Fatty Liver Disease: Unveiling the Mechanisms of Lactobacillus plantarum and Bifidobacterium bifidum in Modulating Lipid Metabolism, Inflammation, and Intestinal Barrier Integrity.
Foods (Basel, Switzerland) (Foods ) Vol: 13 Issue: 18 Pages: Pub: 2024 Sep 21 ePub: 2024 Sep 21 Authors Lu J,Shataer D,Yan H,Dong X,Zhang M,Qin Y,Cui J,Wang L |
| 102 | 📚 |
Protection of Fatty Liver by the Intake of Fermented Soybean Paste, Miso, and Its Pre-Fermented Mixture.
Foods (Basel, Switzerland) (Foods ) Vol: 10 Issue: 2 Pages: Pub: 2021 Feb 1 ePub: 2021 Feb 1 Authors Kanno R,Koshizuka T,Miyazaki N,Kobayashi T,Ishioka K,Ozaki C,Chiba H,Suzutani T |
| 103 | 📚 |
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Free radical biology & medicine (Free Radic Biol Med ) Vol: 102 Issue: Pages: 188-202 Pub: 2017 Jan ePub: 2016 Nov 25 Authors Porras D,Nistal E,Martínez-Flórez S,Pisonero-Vaquero S,Olcoz JL,Jover R,González-Gallego J,García-Mediavilla MV,Sánchez-Campos S |
| 104 | 📚 |
Protein foods from animal sources and risk of nonalcoholic fatty liver disease in representative cohorts from North and South China.
Journal of internal medicine (J Intern Med ) Vol: 293 Issue: 3 Pages: 340-353 Pub: 2023 Mar ePub: 2022 Nov 26 Authors Zhang S,Yan Y,Meng G,Zhang Q,Liu L,Wu H,Gu Y,Wang X,Zhang J,Sun S,Wang X,Zhou M,Jia Q,Song K,Borné Y,Qi L,Chen YM,Niu K |
| 105 | 📚 |
Prunus mume extract and choline treatment in patients with non-alcoholic fatty liver disease estimated by b-mode ultrasonography and hepatorenal index.
Caspian journal of internal medicine (Caspian J Intern Med ) Vol: 15 Issue: 1 Pages: 161-171 Pub: 2024 Winter ePub: Authors Avramovski P,Lazarevski M,Avramovska M,Talev S,Petrovska J,Siklovska V,Sotiroski K |
| 106 | 📚 |
Saccharomyces boulardii Mitigates Fructose-Induced Non-Alcoholic Fatty Liver in Rats.
Medicina (Kaunas, Lithuania) (Medicina (Kaunas) ) Vol: 60 Issue: 10 Pages: Pub: 2024 Oct 18 ePub: 2024 Oct 18 Authors Ulusan M,Erdogan MA,Simsek O,Gunes V,Erbas O |
| 107 | 📚 |
Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model.
Journal of clinical biochemistry and nutrition (J Clin Biochem Nutr ) Vol: 50 Issue: 1 Pages: 72-7 Pub: 2012 Jan ePub: 2011 Aug 24 Authors Xu RY,Wan YP,Fang QY,Lu W,Cai W |
| 108 | 📚 |
Tea Polyphenol Epigallocatechin Gallate Protects Against Nonalcoholic Fatty Liver Disease and Associated Endotoxemia in Rats via Modulating Gut Microbiota Dysbiosis and Alleviating Intestinal Barrier Dysfunction and Related Inflammation.
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: Issue: Pages: Pub: 2024 Apr 12 ePub: 2024 Apr 12 Authors Zuo G,Chen M,Zuo Y,Liu F,Yang Y,Li J,Zhou X,Li M,Huang JA,Liu Z,Lin Y |
| 109 | 📚 |
The Ameliorating Effects of Apple Polyphenol Extract on High-Fat-Diet-Induced Hepatic Steatosis Are SIRT1-Dependent: Evidence from Hepatic-Specific SIRT1 Heterozygous Mutant C57BL/6 Mice.
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 70 Issue: 18 Pages: 5579-5594 Pub: 2022 May 11 ePub: 2022 Apr 29 Authors Yin Y,Li D,Liu F,Wang X,Cui Y,Li S,Li X |
| 110 | 📚 |
The Human Milk Oligosaccharide 2'-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice.
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue: Pages: 904740 Pub: 2022 ePub: 2022 Jun 17 Authors Gart E,Salic K,Morrison MC,Giera M,Attema J,de Ruiter C,Caspers M,Schuren F,Bobeldijk-Pastorova I,Heer M,Qin Y,Kleemann R |
| 111 | 📚 |
The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota.
Life (Basel, Switzerland) (Life (Basel) ) Vol: 14 Issue: 2 Pages: Pub: 2024 Feb 8 ePub: 2024 Feb 8 Authors Hizo GH,Rampelotto PH |
| 112 | 📚 |
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation.
Medicina (Kaunas, Lithuania) (Medicina (Kaunas) ) Vol: 60 Issue: 4 Pages: Pub: 2024 Mar 29 ePub: 2024 Mar 29 Authors Abenavoli L,Gambardella ML,Scarlata GGM,Lenci I,Baiocchi L,Luzza F |
| 113 | 📚 |
The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu.
Biomedical and environmental sciences : BES (Biomed Environ Sci ) Vol: 25 Issue: 4 Pages: 383-91 Pub: 2012 Aug ePub: Authors Shi L,Liu ZW,Li Y,Gong C,Zhang H,Song LJ,Huang CY,Li M |
| 114 | 📚 |
The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet.
Food & function (Food Funct ) Vol: 11 Issue: 4 Pages: 3316-3331 Pub: 2020 Apr 30 ePub: Authors Chen M,Guo WL,Li QY,Xu JX,Cao YJ,Liu B,Yu XD,Rao PF,Ni L,Lv XC |
| 115 | 📚 |
The synbiotic combination of probiotics and inulin improves NAFLD though modulating gut microbiota.
The Journal of nutritional biochemistry (J Nutr Biochem ) Vol: 125 Issue: Pages: 109546 Pub: 2024 Mar ePub: 2023 Dec 8 Authors Zhang C,Fang T,Shi L,Wang Y,Deng X,Wang J,Zhou Y |
| 116 | 📚 |
The synchronized feature of Saururus chinensis and gut microbiota against T2DM, NAFLD, obesity and hypertension via integrated pharmacology.
Artificial cells, nanomedicine, and biotechnology (Artif Cells Nanomed Biotechnol ) Vol: 52 Issue: 1 Pages: 278-290 Pub: 2024 Dec ePub: 2024 May 11 Authors Oh KK,Yoon SJ,Song SH,Park JH,Kim JS,Kim DJ,Suk KT |
| 117 | 📚 |
Therapeutic Effects of Curcuminoids and Silymarin, Individually and in Combination, in Patients With Hepatic Impairment.
Chemistry & biodiversity (Chem Biodivers ) Vol: Issue: Pages: e03340 Pub: 2025 Jun 13 ePub: 2025 Jun 13 Authors Elgendy EM,El Sherbiny WA,Sedki AG,Gaber HH |
| 118 | 📚 |
Therapeutic potential of Lactobacillus casei and Chlorella vulgaris in high-fat diet-induced non-alcoholic fatty liver disease (NAFLD)-associated kidney damages: a stereological study.
Molecular biology reports (Mol Biol Rep ) Vol: 51 Issue: 1 Pages: 613 Pub: 2024 May 5 ePub: 2024 May 5 Authors Keyghobadi H,Bozorgpoursavadjani H,Koohpeyma F,Mohammadipoor N,Nemati M,Dehghani F,Jamhiri I,Keighobadi G,Dastghaib S |
| 119 | 📚 |
Therapeutic Role of Polyphenol Extract from Prunus cerasifera Ehrhart on Non-Alcoholic Fatty Liver.
Plants (Basel, Switzerland) (Plants (Basel) ) Vol: 13 Issue: 2 Pages: Pub: 2024 Jan 18 ePub: 2024 Jan 18 Authors Ren J,Zhang X,Heiyan-Perhat SU,Yang P,Han H,Li Y,Gao J,He E,Li Y |
| 120 | 📚 |
Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD).
International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition (Int J Vitam Nutr Res ) Vol: 89 Issue: 5-6 Pages: 293-302 Pub: 2019 Nov ePub: 2019 Apr 24 Authors Ghaffari A,Rafraf M,Navekar R,Sepehri B,Asghari-Jafarabadi M,Ghavami SM |
| 121 | 📚 |
Wheat germ improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
Phytotherapy research : PTR (Phytother Res ) Vol: 36 Issue: 11 Pages: 4201-4209 Pub: 2022 Nov ePub: 2022 Jul 17 Authors Salehi-Sahlabadi A,Kord-Varkaneh H,Kocaadam-Bozkurt B,Seraj SS,Alavian SM,Hekmatdoost A |
The following items have been cited in the above studies
| ID | Studies | Name | AKA |
|---|---|---|---|
| 40 | 2 | 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} | Found in goldenseal, Chinese goldthread, barberry, tree turmeric, Oregon grape |
| 206 | 2 | (2->1)-beta-D-fructofuranan {Inulin} | Fructan, Polyfructose, Alpha-D-glucopyranosyl-beta-D-fructofuranosyl-D-fructofuranoside, usually from Chicory root, Jerusalem artichoke |
| 349 | 1 | 3,3',4',5,7-pentahydroxyflavone {Quercetin} | quercetin aglycone,bioflavonoid,a type of flavonol |
| 316 | 2 | alpha-linolenic acid {Omega-3} | ALA. Plant based, Flaxseed, otherwise see Fish oil NOT a-Lipoic acid (also ALA) |
| 1912 | 1 | alpha-tocopherol {Vitamin E} | including four tocopherols (alpha, beta, gamma, delta) and four tocotrienols (alpha, beta, gamma, delta) |
| 2952 | 1 | Arctium lappa {Burdock Root} | Lappa,Beggar's buttons,Thorny burr,Happy major,Fox's clote,Cockle buttons,Love leaves,Philanthropium,Personata,Clot-bur |
| 1936 | 1 | Arthrospira platensis {Spirulina} | Blue-green algae,Tecuitlatl |
| 22 | 1 | ascophyllum nodosum {Rockweed} | sea weed,Knotted Wrack,Norwegian Kelp,Rockweed,Fucus nodosus |
| 32 | 1 | bacillus subtilis {B.Subtilis } | Hay bacillus, grass bacillus,Vibrio subtilis |
| 33 | 1 | bacillus subtilis,lactobacillus acidophilus | |
| 1753 | 3 | bifidobacterium | b (probiotics) |
| 46 | 1 | Bifidobacterium animalis subsp. lactis {B. Lactis} | Includes BB-12, DN-173 010 ,Bifidobacterium Regularis,Bifidus Regularis |
| 1737 | 2 | bifidobacterium bifidum {B. bifidum} | |
| 50 | 2 | bifidobacterium longum {B.Longum } | May include Bifidobacterium longum subsp. infantis and Bifidobacterium longum subsp. longum |
| 444 | 1 | blueberry | |
| 90 | 1 | Cichorium intybus {Chicory} | Blue daisy,Blue dandelion,Blue sailors,Blue weed,Bunk,Coffeeweed |
| 2980 | 1 | Coenzyme Q10 {CoQ 10} | Ubiquinone,Ubidecarenone,Vitamin Q10,Mitoquinone |
| 2856 | 2 | Coffee | |
| 2927 | 1 | Curcuma longa {Turmeric} | Indian Saffron,Yellow Ginger,Kunyit,Haldi |
| 1824 | 2 | Diferuloylmethane {Curcumin} | Extract from Turmeric (which contains other chemicals) |
| 129 | 2 | Epicatechin {Green tea polyphenol} | Epigallocatechin-3-gallate (EGCG),(-)-Epicatechin, Found in Camellia sinensis (tea plant),Cecropia hololeuca,Apples,Cocoa |
| 1807 | 1 | Finnish Probiotic {Valio Probiotic} | lactobacillus rhamnosus gg,lactobacillus,rhamnosus,propionibacterium freudenreichii,bifidobacterium breve |
| 2889 | 1 | Glycine max x Aspergillus oryzae {Miso} | Japanese fermented soybean paste made with Aspergillus oryzae |
| 171 | 2 | glycyrrhizic acid {licorice} | Glycyrrhiza glabra,liquorice |
| 176 | 1 | green tea | |
| 37 | 2 | Hordeum vulgare {Barley} | Hordeum irregulare,Hordeum distichon |
| 1674 | 1 | Human milk oligosaccharides (prebiotic, Holigos, Stachyose) | Stachyose,2'-Fucosyllactose ,2'-FL |
| 234 | 3 | Lacticaseibacillus casei {L. casei} | Streptobacterium casei,Lactobacillus casei |
| 241 | 5 | Lacticaseibacillus paracasei {L.paracasei} | Was also known as Lactobacillus casei subsp. pseudoplantarum |
| 246 | 1 | Lacticaseibacillus rhamnosus {l. rhamnosus} | lactobacillus rhamnosus, Lactobacillus casei subsp. rhamnosus |
| 230 | 3 | lactobacillus acidophilus {L. acidophilus} | Bacillus acidophilus |
| 3144 | 1 | Lactobacillus Johnsonii {Lactobacillus Johnsonii} | Taxonomy ID: 33959 |
| 243 | 8 | Lactobacillus plantarum {L. plantarum} | lactobacillus plantarum, Lactobacillus arabinosus |
| 247 | 1 | lactobacillus rhamnosus gg | l rhamnosus gg (probiotics) |
| 3185 | 2 | Lactococcus lactis {Streptococcus lactis} | |
| 236 | 2 | Limosilactobacillus fermentum {L. fermentum} | Lactobacillus fermentum |
| 245 | 1 | Limosilactobacillus reuteri {L. Reuteri} | Lactobacillus fermentum subsp. reuteri |
| 2818 | 1 | long-term, moderate-intensity exercise {exercise} | Shifts not seen with short-term, high-intensity exercise |
| 1780 | 1 | low protein diet | |
| 1687 | 1 | Malus domestica {apple} | Apple skin |
| 284 | 1 | metformin (prescription) | (actos met, adglim-m, aglikem, alexodiab, amaryl m, amaryl m forte, amaryl m sr, amophage, andibet, anglucid, anhe, asegur, asoformin, asoformin-p, asoride-m, avandamet, belformin, benforce-m, bidimefor, bi-euglucon m, bigesens, bigesens-xr, biguanil, bigwin xr, bioglita plus, blisto-mf, brot, cereluc met, cetapin-p, cetapin-v, cetapin-xr, cidophage, cidophage ret., claz-m, coamaryl, comiaryl, competact, daocon-m, daonil m, daoride-m, dbi, diab dos, diacriptin-m, diafer, diafer forte, diafer-er, diaformin, diaformina, diaformine, dialon, diamet, dianorm xr, dianorm-m, diaphage, diaphage sr, diapride forte, diapride plus, diaquit, diavance, diavista-m, diazero-m, dibimet, diglumet, dimefor, dimet, dior, dior plus, dior-sr, dipride-m, dipride-m plus, dmbest, dmbest-sr, dropia-met, duo-anglucid, engilor, eucreas, euglim-m, euglumide plus, exmet-sr, formagliben, formidiab, formidiab retard, formilab, freed no. 25, galvumet, galvus met, galvusmet, galvus-met, glamor-m, glange, glemaz met, glibact-m, glibemet, glibomet, glicenex, glicenex duo, glicenex sr, gliclamet, glicol-m, glidiet-m, glifage, gliformin, glimaday, glimaday forte, glimaday-hs, glimefine-m, glimestar-m, glimet, glimet forte, glimet-ds, glimex-m, glimi dm forte, glimid-m, glimifix-m, glimilex-m, glimulin-mf, glimy-m, glinate-mf, glinil met, glinorm-m, glista, glital-m, glitz-mf, glizone-m, glm, glp-m, glucaminol, glucoact-m, glucofage, glucofage xr, glucofor-g, glucoformin, glucolight xr, gluconorm sr, gluconorm-p, glucophage, glucophage long, glucophage xr, glucotrac, glucovance, gluforce, gluformin, gluformin er, gluformin-g, gluformin-g forte, gluformin-xl, glumetin, glunor-xr, gluokan, gluquinal, gluquinal xr, glustacomb, glutec, glybformin, glybofen, glycimex-m, glyciphage, glyciphage-g, glyciphage-p, glycomet, glycurb, glycurb forte, glyformin, glymef, glymet, glymin plus, glynase-mf, glysiss-m, glystor, glystor plus, glyzee-m, g-met, g-met forte, gride-m, gride-m forte, grip-m, hipoglucin, hipoglucin da, hipoglut met, icandra, iscept, iscept forte, isloglib, islotin, janmet, janumet, jentadueto, k-met, komboglyze, lita-m xr, matofin, meburide, mectin, mefoglip ds, mefomin, mefomin-p, meforex, meglipride-m, meglucan, meglucon, melgib, melitus, melitus forte, mesite-xr, met forte, metaday, metadoze, metclam, metclam forte, metclamide, metfine, metfogamma, metfor, metforal, metfordan, metfordan-g, metformed, metformin adwic, metformin dha, metformin mylan, metformin replek farm, metformin sunward, metformin vitabalans, metformina, metformina actavis, metformina aurobindo, metformina colmed, metformina kronos, metformina mylan generics, metformina opko, metformina puntanos, metformina sandoz, metformina tauro, metformina techsphere, metformina teva, metformina vannier, metformina winthrop, metformina/glibenclamida mk, metformine arrow lab, metformine winthrop, metformin-teva, metfortabs, metfull, metgliben, metglital, metgluk, methpica, metlong-ds, metride, met-xr, minson-g, monomet-gm, monomet-xl, mopaday, mopaday forte, mopaday-hs, mr-met, mthl, n-met, n-met g, nvmet, obax, obimet, olglimide-m, piodart-mf, pioglar-m, pioglumet, pionorm-m, posmeal-met, ppg-met, predial, preko, q-met, q-met xl, quexel, riomet, ristfor, rosi plus, salidiab ap 1000, sangly-m, serdenis, sil-norboral, siofor, sioral retard, sitamet, sitar-m, starlix combi, suguan m, synjardy, tefor, trayenta duo, vedapride, vedapride-m, velmetia, vidzid-m, vipdomet, viqugim-m, voglicad-m, voglimac-mf, vokanamet, volabay-m, voliphage-m, walaphage, xigduo, xmet, xmet-sr, zeformin-xr, ziglim-m, zoform, zomelis-met, zuker-mf, stagid, accord metformin, actomeg, actoplus met, actoplus met xr, actos m, actosmet, adecco, adimet, adride-m, agimfor, aglumet, aglurab, amaryl combi, amaryl xm, ammiformin, andm, anformin, ankomin, ansures, ansures er, antigluco, anxofin, anxoken, apo-metformin, aromet, arrow metformine hcl, asformin, austell-metformin, avamina, azulix-mf, bai kang, bai si ping, baligluc, bei shun, benformin, benformin-hs, benformin-ls, benofomin, ben-q-met, ben-q-met forte, ben-q-met ls, bentomin, betaform, betaglim-m, bicanol, bidiab, bigmet, bigomet, bigsens, bigsens xr, biguax, bo ke, boie metformin hcl, brot formin, c.t.l. xr, ccm metformin, chemmart metformin, claformin, climeril m, comet, comet xr, compimet, cp-metform, dabex, dabex xr, daomin, daonil + metformin, dbi duo, de ai xin, debeone d.t. nf, debeone nf, deson, diabesel, diabesil, diabesin, diabetex, diabetil, diabetil plus, diabetmin, diabetmin retard, diabetormin, diabetrol, diabex, diabex xr, diabit, diafac, diafat, diaformina plus, diagemet xl, diaglimet, diaglinex-m, diagraph-m, dialiptin-m, diamed, diamide, diamin, dianben, diareg, diaset-m sr, diaslim, dibimet plus, dibizide-m, diformin retard, dimefor-g, dinamel, dinorax, dinorax c, diolan, dior-g, diout, dipimet, du he, du le ning, duburina, duotrol-sr, dybis, efficib, efinex met, efomet, emiphage, emnorm er, endial met, eraphage, estuvina, etform, euform retard, euglo plus, feximet, ficonax, forbetes, fordex, fordia, formell, formet, formetic, formetin, forminal, formit, fornidd, fortamet, fulaihe, furuitong, galvan plus, galvus met combo-pack, gan li ke fu, ge shuang, ge wan si, gemer, g-formin, gladin m, glaformin sr, glaformin-m, glafornil, glafornil xr, glatix-m, gleminex, glibudon, gliclafin-m, glicmet, glicmet forte, gliconorm, glicorest, gliczee-m, glidanil, glidanil xr, glidanil-g, glifix-plus, glifor, glifortex, glifortex g, glifortex xr, glikos, glimcare forte, glimcare plus, glimekomb, glimel-m, glimepine m, glimetal, glimex er, glimiprime-m, glimsite-m, glimulin-mf forte, glipixor-m, glipizide and metformin hydrochloride actavis, glitafor-xr, glitrac-m, glizid-m, glu-a, glubin, glubrava, glucaminol forte, glucare, glucibetina-t, glucient sr, gluclean, glucocid, glucodown, glucodown sr, glucodue, glucofine, glucofit, glucofor, glucoform, glucofree, glucogen, glucogood, glucolyte, glucomed, glucomet, glucomet xr, glucomin, glucomine, glucon, gluconorm, gluconorm-g, glucophage sr, glucoplus, glucored forte, glucotika, glucotin, glucotrac plus, glucovance mite, gludepatic, gludex plus, gludin, glufor, glugenmin, glukaut, glukofen, glumet, glumet xr, glumet-forte, glumetsan, glumetza, glumin, glumin puls, glumin-xr, glunor, glupa, gluzolyte, glybonil plus, glyburide and metformin hydrochloride actavis, glycomet-gp, glycomet-gp forte, glycomin, glycon, glycoran, glyloc-m, glymef-mf, glymin, glymin xr, glyred-m, glyvik-m, g-phase, gradiab, grimefol sr, guamet, hasanbest, he wei yi, henformin, heskopaq, hi-met, hipoglucin lp, hong fei kang, hovideuform, hui luo ping, humamet, ilimin, i-max, informet, informet la, insimet, insogen plus, insumed, invokamet, islotin xr, isryl-m, jalra m, januet, januet xr, janumet xr, jardiance met, jiang li shu, jiang xi, jin ping tang, jinzhenxing, juformin, jun fu le, jun li da, jun shi da xin, jznumet, kazano, ke mai ning, keruite, k-gem, kombiglyze xr, langerin, li jiang, li le er, li li le, li li nuo, li sheng yuan, lian he tang ding, lian jiang, loditon, lupimet, lvtangsu, mai ke luo xin, marphage, maviglin, mecfoc, mectin xr, medet, medobis, medobis g, mefoglip, meforal, meforin, meforin-xr, meformed, megaformin, megaformin er, meglu, meglucon hexal, meglucon sandoz, meglu-er, meglumine unifarma, meguan, meguanin, mei jia te, mekoll, melbin, mellimet g, mellinix, memin, mengen, merckformin, merckformin xr, meritor, met, metact hd, metact ld, metaglip, metanorm, metbay, metdual, metex xr, metfen, metfin, metfirex, metfobay, metfocell, metfodiab, metfogen, metfoliquid geriasan, metfonorm, metforalmille, metforem, metforex, metforil, metform, metformax, metformax sr, metformin - 1 a pharma, metformin 1a pharma, metformin -500, metformin abz, metformin accedo, metformin actavis, metformin al, metformin alapis, metformin alpharma, metformin apotex, metformin arcana, metformin arena, metformin aristo n, metformin aurobindo, metformin axapharm, metformin bluefish, metformin borisov, metformin bristol, metformin charoen bhaesaj, metformin chen ho, metformin cherubino, metformin chinoin, metformin comp hexal, metformin denk, metformin duo, metformin dura, metformin eql pharma, metformin europharma, metformin focus, metformin galena, metformin generichealth, metformin genericon, metformin generics, metformin glenmark, metformin gpo, metformin gsk, metformin hcl ogb dexa, metformin helvepharm, metformin hexal, metformin hydrochloride, metformin hydrochloride actavis, metformin hydrochloride alkem, metformin hydrochloride rosemont, metformin hydrochloride sn, metformin hydrochloride towa, metformin hydrochloride zentiva, metformin ivax, metformin leciva, metformin lich, metformin lide, metformin lph, metformin meda, metformin orifarm, metformin pfizer, metformin pfoshen, metformin pharmabart, metformin pharmacin, metformin ranbaxy, metformin ratiopharm, metformin rth, metformin rx, metformin sandoz, metformin sanis health, metformin spirig hc, metformin sr actavis, metformin srbolek, metformin stada, metformin streuli, metformin synpac-kingdom, metformin tchaikapharma, metformin temis, metformin teva, metformin usv, metformin vale, metformin weifa, metformin winthrop, metformin winthrop mr, metformin wockhardt, metformin worwag, metformin yung chi, metformin yung sine, metformina + glibenclamida ramos, metformina almus, metformina amneal, metformina andromaco, metformina apotex, metformina azevedos, metformina basi, metformina bluefish, metformina ciclum, metformina cinfa, metformina clorhidrato anglopharma, metformina clorhidrato ascend, metformina combix, metformina doc generici, metformina edigen, metformina eg, metformina generis, metformina hexal, metformina kern pharma, metformina l.ch., metformina labesfal, metformina mk, metformina mylan, metformina mylan pharmaceuticals, metformina parke-davis, metformina pensa, metformina pensa pharma, metformina pharmakern, metformina qualigen, metformina ramos, metformina ratiopharm, metformina romac, metformina sanitas, metformina solumet, metformina stada, metformina teva italia, metformina wynn, metformina zentiva, metformina/glibenclamida medley, metformin-ct, metformine actavis, metformine alter, metformine arrow, metformine bgr, metformine biogaran, metformine bluefish, metformine cristers, metformine eg, metformine evolugen, metformine hcl a, metformine hcl actavis, metformine hcl amneal, metformine hcl apotex, metformine hcl aurobindo, metformine hcl bb, metformine hcl bluefish, metformine hcl ceft, metformine hcl cf, metformine hcl disper mylan, metformine hcl mylan, metformine hcl pch, metformine hcl pfizer, metformine hcl ratiopharm, metformine hcl sandoz, metformine hcl teva, metformine hcl usv, metformine hcl/glibenclamide sandoz, metformine hydrochloride mylan, metformine mylan, metformine mylan pharma, metformine ranbaxy, metformine ratiopharm, metformine rpg, metformine sandoz, metformine teva, metformine zentiva, metformine zydus, metformine zydus france, metformin-ga, metformin-ratiopharm, metformin-teva xr, metformin-zentiva, metforteg, metfromin hydrochloride xr actavis, metfron, metgluco, metglucon, metglucon duo, metgreen-sr, methormyl, metifor, metiglit, metmaryl, metmaryl sr, metmen, metnil, metnova, meto, metophage xr, metored, metphage, metphar, metta sr, miformin, mignar-mf, ming nuo, mitforgen, mydiatab, mylan metformin, mylmet, na xun, nelbis, neoform, neoformin, neomaryl m, neomet, nesina met, nevox, nidcor, nilgar m, nobesit, nobesit xr, norfaben m, norfarben m, normaglyc, normell, novamet, novogard, nvmet-sr, o-berry-m, obid, obimet-gx, omformin, oramet, oramet plus, oramet-sr, orinase-met, ormin, oxemet, panfor sr, panformin, perglim, pharex metformin, pharmacor metformin, pioglaz-m, pioglaz-m forte, pioglite plus, piol-m, pio-m, pionix-m, pioplus, pio-q plus, piozena, pms-imephase, pms-metformin, pocophage, politor, prandimet, predial lex, predial plus, preform, preform-sr, prialta-met, prizide-m, pu le kang ni, pymetphage, qi ji, qi ting, qi zhi ping, qing kuang, ran-metformin, reclimet, reduluc, reglus, ren xin, rezulin, risidon, ristaben met, ritemed metformin, riva-metformin, rosimet, rotamin, rotamin ds, rui lian, rui nuo shu, ruijiu, san xiao ping, sandoz metformin, sandoz metformin fc, sensimet, sensimet ds, shan mu shi, sheng bang jie, shi ke yi, shuang ge ning, shuang li, shuang ping le, si yi, siamformet, siglimet, simelin, sliptin-m, slosugar, slowmet, solosamet, sophamet, stadamet, starform, sucrovance, sugadrop, sugamet, suglit-xr, sukontrol, tai bai, tai bi, tang bei kang, tang bi fu, tang ge, tang ke jie, tang ke ning, tang li ke, tang ping, tang rui ping, tang tan, terry white chemists metformin, teva-metformin, tiglor, trajenta - duo, trajenta duo, treviamet, troge metformin hydrochloride, tudiab, uformin, urimin, v-bose-m, vocarb-mf, vogmet, vogs-m, volv, wadil, walaphage gp, wan su qi, wei er tang, weiyi, winthrop metformin hcl, xigduo xr, xin shu shi ning, xin tang ping, yi fu yun, yi heng, yi ke fu, yi sha ning, yue da ning, zendiab, zhao wei, zhong shi de, zilmet, zipio-m, zolidplus, zomarist, zomarist met, zuglimet) |
| 301 | 2 | naringenin {grapefruit} | Naringin flavanone (Citric Fruits) |
| 1719 | 2 | Nigella sativa {black cumin} | black seed, black caraway, kalonji,fennel flower |
| 1743 | 1 | oligosaccharides {oligosaccharides} | includes Fructo-oligosaccharides (FOS),Galacto-oligosaccharides (GOS),Mannan oligosaccharides (MOS),Human milk oligosaccharides (HMOs) |
| 318 | 1 | origanum vulgare {oregano} | oregano oil, capsules. 50% is carvacrol and thymol |
| 2961 | 1 | Panax ... {Ginseng} | Asian or Korean ginseng,American ginseng,Renshen,Baiguo |
| 2821 | 1 | Prunus mume {Umeboshi} | Japanese pickled plum,Salted Japanese plum,Pickled ume,Dried ume |
| 359 | 2 | Pyroguaiac acid {Guaiacol} | polyphenol, includes Eugenic acid. found in Coffee, smoked foods, Scotch Whiskey |
| 353 | 1 | red wine | |
| 358 | 1 | resistant starch | high resistant starch |
| 360 | 2 | resveratrol-pterostilbene {grapes, blueberries} | grape seed/polyphenols/red wine |
| 368 | 1 | Saccharomyces cerevisiae var boulardii {S. boulardii} | brewer's yeast |
| 1713 | 1 | sarcodiotheca gaudichaudii {Red Seaweed} | succulent seaweed |
| 1897 | 2 | Silybum marianum {milk thistle} | Blessed thistle,Mary thistle,Scotch thistle,Holy thistle,St. Mary's thistle,Marian thistle,Mediterranean milk thistle,Variegated thistle |
| 1928 | 1 | Solanum tuberosum {Potatoes} | Spud,Tater,Earth apple |
| 382 | 1 | soy | Soymilk |
| 4523 | 1 | Streptococcus salivarius subsp. thermophilus {S. thermophilus} | Streptococcus thermophilus |
| 281 | 2 | Traditional Mediterranean diet {Mediterranean diet} | Mediterranean-style diet,Mediterranean eating pattern,Mediterranean dietary pattern |
| 3170 | 1 | Trichosanic acid {pomegranate seed oil} | Punicic acid |
| 1684 | 1 | vegetarians | lacto-ovo-vegetarian diet |
| 424 | 1 | vitamin d | cholecalciferol,Vitamin D3, activated 7-dehydrocholesterol |
| 429 | 1 | wheat |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
